<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04163042</url>
  </required_header>
  <id_info>
    <org_study_id>20190643-01H</org_study_id>
    <nct_id>NCT04163042</nct_id>
  </id_info>
  <brief_title>Physical Activity Counselling for Young Adult Cancer Survivors</brief_title>
  <official_title>Physical Activity Counselling for Young Adult Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ottawa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ottawa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Survival rates for cancer are increasing, resulting in more young adult cancer survivors
      living with lingering side effects. Physical activity has been shown to improve the quality
      and length of life in young adult cancer survivors; yet, few are active enough, and little is
      currently being done to promote physical activity in this population. Therefore, the purpose
      of this 3-arm pilot randomized controlled trial is to explore the feasibility and
      acceptability of a behavioural support intervention aimed at promoting physical activity
      among young adult cancer survivors, which will be delivered either in-person or via
      videoconferencing.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recruitment rates</measure>
    <time_frame>Duration of study (24 months)</time_frame>
    <description>The number of eligible participants who enrol in the trial out of the number who are referred</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adherence rates</measure>
    <time_frame>Duration of study (24 months)</time_frame>
    <description>The number of intervention sessions attended out of the total recommended as part of the intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability of the trial and intervention</measure>
    <time_frame>At week 12</time_frame>
    <description>Participants will be asked to share their experiences, thoughts, and perspectives of the trial, the physical activity counsellor and the intervention by responding to open and close-ended questions during a semi-structured interview. Responses to close-ended questions will range from 1 ('poor' or 'not satisfied at all') to 10 ('excellent' or 'extremely satisfied').</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retention rates</measure>
    <time_frame>Duration of study (24 months)</time_frame>
    <description>The number of participants completing all three scheduled assessments.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Data completeness: Quantitative measures</measure>
    <time_frame>Duration of study (24 months)</time_frame>
    <description>The percentage of missing data on quantitative measures.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Data completeness: Qualitative interviews</measure>
    <time_frame>Duration of study (24 months)</time_frame>
    <description>The number of participants completing the acceptability interview following the intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical activity behaviour: 7-day accelerometer wear (objective physical activity behaviour)</measure>
    <time_frame>Baseline (week 0), post-intervention (week 12), post-intervention follow-up (week 24)</time_frame>
    <description>Change in participants' objective levels of physical activity as measured by accelerometers (ActiGraph GT3X+), which will be worn for a 7-day period across baseline (week 0), post-intervention (week 12), and follow-up (week 24).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life: RAND 36-Item Short Form Health Survey (SF-36; Ware &amp; Sherbourne, 1992)</measure>
    <time_frame>Baseline (week 0), post-intervention (week 12), post-intervention follow-up (week 24)</time_frame>
    <description>Change in participants' self-reported health-related quality of life across baseline (week 0), post-intervention (week 12) and post-intervention follow-up (week 24). The SF-36 measures eight dimensions: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health. Each item is scored on a 0 to 100 scale, with higher scores representing a more favourable health state.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive and negative affect: Positive and Negative Affect Schedule (PANAS-SF; Watson, Clark &amp; Tellegen, 1998)</measure>
    <time_frame>Baseline (week 0), post-intervention (week 12), post-intervention follow-up (week 24)</time_frame>
    <description>Change in participants' self-reported positive and negative affect across baseline (week 0), post-intervention (week 12) and post-intervention follow-up (week 24). Each item is scored on a scale from 1 ('Very slightly or not at all') to 5 ('Extremely'). Items in the positive scale are averaged together to create a Positive Affect Score, and items in the negative scale are averaged together to create a Negative Affect Score. Higher positive and negative scores represent higher positive and negative affect, respectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depressive symptoms: Patient Health Questionnaire Depression Scale (PHQ-9; Kroenke, Spitzer &amp; Williams, 2001)</measure>
    <time_frame>Baseline (week 0), post-intervention (week 12), post-intervention follow-up (week 24)</time_frame>
    <description>Change in participants self-reported depressive symptoms across baseline (week 0), post-intervention (week 12) and post-intervention follow-up (week 24). Each item is scored on a 0 ('Not at all') to 3 ('Nearly every day') scale with higher scores representing greater severity of depressive symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety symptoms: 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7; Kroenke, Spitzer &amp; Williams, 2006)</measure>
    <time_frame>Baseline (week 0), post-intervention (week 12), post-intervention follow-up (week 24)</time_frame>
    <description>Change in participants self-reported anxiety symptoms across baseline (week 0), post-intervention (week 12) and post-intervention follow-up (week 24). Each item is scored on a 0 ('Not at all') to 3 ('Nearly every day') scale, with higher scores representing greater severity of anxiety symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of cancer: Impact of Cancer Instrument - Adolescent and Young Adult Module (Husson &amp; Zebrack, 2017)</measure>
    <time_frame>Baseline (week 0), post-intervention (week 12), post-intervention follow-up (week 24)</time_frame>
    <description>Change in participants' self-reported perceptions of cancer impact from baseline (week 0), post-intervention (week 12) and post-intervention follow-up (week 24). Each item is scored on a scale from 0 ('Strongly disagree') to 4 ('Strongly agree'), with higher scores representing greater impact of cancer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motivation for physical activity: Behavioural Regulation in Exercise Questionnaire-3 (BREQ-3; Markland &amp; Tobin, 2004)</measure>
    <time_frame>Baseline (week 0), post-intervention (week 12), post-intervention follow-up (week 24)</time_frame>
    <description>Change in participants' self-reported motivation for physical activity across baseline (week 0), post-intervention (week 12) and post-intervention follow-up (week 24). This measure taps six behavioural regulations in the physical activity context: amotivation, external, introjected, identified, integrated, and intrinsic motivation. Each item is scored on a scale from 0 ('Not true for me') to 4 ('Very true for me'), with higher scores reflecting greater amotivation, external, introjected, identified, integrated, and intrinsic motivation for physical activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Basic psychological need satisfaction in relation to physical activity: Psychological Need Satisfaction in Exercise Scale (PNSE; Wilson, Rogers &amp; Rodgers, 2006)</measure>
    <time_frame>Baseline (week 0), post-intervention (week 12), post-intervention follow-up (week 24)</time_frame>
    <description>Change in participants self-reported psychological need satisfaction in relation to physical activity across baseline (week 0), post-intervention (week 12) and post-intervention follow-up (week 24). The PNSE measures perceptions of competence, autonomy and relatedness in relation to physical activity. Each item is scored on a scale from 1 ('False') to 6 ('True'), with higher scores representing greater perceived competence, autonomy and relatedness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Autonomy support, structure and interpersonal involvement: Health Care Climate Questionnaire (Marcus et al., 1992)</measure>
    <time_frame>Post-intervention (week 12)</time_frame>
    <description>Participants perceived sense of autonomy support, structure and interpersonal involvement for physical activity post-intervention (week 12). Each item is scored on a scale from 1 ('Strongly disagree') to 7 ('Strongly agree'), with higher scores representing greater perceived autonomy support, structure and interpersonal involvement for physical activity.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Socio-Demographic and Medical Information Questionnaire</measure>
    <time_frame>Baseline (week 0)</time_frame>
    <description>Self-reported socio-demographic and medical information (e.g., age, gender, civil and educational status, ethnicity) will be collected and used to describe the sample. Participants will be provided with a range of response options for each item.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Survivorship</condition>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Group A: Videoconferencing intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants allocated to group A will receive a behavioural support intervention via real-time videoconferencing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B: In-person intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants allocated to group B will receive a behavioural support intervention in-person at the University of Ottawa.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C: Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants allocated to group C will receive usual care and will be advised to continue with their regular activities of daily living.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>12-week videoconferencing behavioural support intervention to promote physical activity behaviour</intervention_name>
    <description>Participants in Group A will receive six real-time, 1-on-1 60-minute sessions led by a physical activity counsellor over a 12-week period. Sessions will be delivered either via videoconferencing and will aim to provide young adult cancer survivors with support as well as the knowledge, skills, and confidence to identify and overcome challenges to engaging in physical activity in order to increase physical activity behaviour and enhance patient-reported outcomes.</description>
    <arm_group_label>Group A: Videoconferencing intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>12-week in-person behavioural support intervention to promote physical activity behaviour</intervention_name>
    <description>Participants in Group B will receive six real-time, 1-on-1 60-minute sessions in person led by a physical activity counsellor over a 12-week period. Sessions will be delivered in-person at the University of Ottawa and will aim to provide young adult cancer survivors with support as well as the knowledge, skills, and confidence to identify and overcome challenges to engaging in physical activity in order to increase physical activity behaviour and enhance patient-reported outcomes.</description>
    <arm_group_label>Group B: In-person intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Currently between the ages of 18-39 years;

          -  Received a first diagnosis of invasive cancer between the ages of 18-39 years;

          -  Completed primary treatment for cancer &lt;5 years;

          -  Able to provide informed consent in English or French;

          -  Have approval of a healthcare provider to participate in the trial;

          -  Have access to videoconferencing technology (e.g., Skype, Google Hangouts, Facetime);

          -  Able and willing to travel to the University of Ottawa

        Exclusion Criteria:

          -  Have evidence of current cancer (recurrent or secondary cancer or relapse);

          -  Currently meeting the Canadian Society for Exercise Physiology aerobic physical
             activity guidelines for cancer survivors in the month prior to enrolment (i.e., 150
             minutes/week of moderate-to-vigorous intensity aerobic physical activity);

          -  Are non-ambulatory
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Meagan Barrett-Bernstein, MSc</last_name>
    <phone>613-562-5800</phone>
    <phone_ext>7300</phone_ext>
    <email>meagan.barrett-bernstein@uottawa.ca</email>
  </overall_contact>
  <reference>
    <citation>Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.</citation>
    <PMID>1593914</PMID>
  </reference>
  <reference>
    <citation>Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70.</citation>
    <PMID>3397865</PMID>
  </reference>
  <reference>
    <citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.</citation>
    <PMID>11556941</PMID>
  </reference>
  <reference>
    <citation>Spitzer RL, Kroenke K, Williams JB, LÃ¶we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7.</citation>
    <PMID>16717171</PMID>
  </reference>
  <reference>
    <citation>Husson O, Zebrack BJ. Psychometric Evaluation of an Adolescent and Young Adult Module of the Impact of Cancer Instrument. J Adolesc Young Adult Oncol. 2017 Mar;6(1):159-170. doi: 10.1089/jayao.2016.0038. Epub 2016 Sep 21.</citation>
    <PMID>27654343</PMID>
  </reference>
  <reference>
    <citation>Marcus BH, Rakowski W, Rossi JS. Assessing motivational readiness and decision making for exercise. Health Psychol. 1992;11(4):257-61.</citation>
    <PMID>1396494</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>November 5, 2019</study_first_submitted>
  <study_first_submitted_qc>November 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2019</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ottawa</investigator_affiliation>
    <investigator_full_name>Jennifer Brunet</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Physical activity</keyword>
  <keyword>Behavioural support</keyword>
  <keyword>Oncology</keyword>
  <keyword>Telehealth</keyword>
  <keyword>Self-determination theory</keyword>
  <keyword>Behaviour change techniques</keyword>
  <keyword>Young adult cancer survivors</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

